Skip to main content
Discovering the causes of cancer and the means of prevention

Infections and Immunoepidemiology Training Opportunities with Specific Investigators

Epidemiology of Cancer in Immunosuppressed Populations – Postdoctoral Fellowship

Dr. Eric Engels and Dr. Meredith Shiels of the Infections and Immunoepidemiology Branch (IIB) are seeking a postdoctoral fellow interested in the epidemiology of cancer in immunosuppressed populations.

Specific risk factors for cancer that will be a focus of research include HIV infection, solid organ transplantation, autoimmune diseases, use of immunosuppressive medications, and viral infections.

Qualifications: Candidates should possess a strong background and skill in epidemiology, particularly in relation to infectious causes of cancer; statistical analysis; and critical thinking and writing. There will be opportunities to lead pre-defined projects. In addition, new fellow-initiated projects are encouraged. The fellow will also have the ability to work with other investigators in IIB to gain experience in other areas of research.

For more information about this position, please contact Eric Engels, M.D., M.P.H., Chief and senior investigator, or Meredith Shiels, Ph.D., investigator.

To Apply: See the Division Fellowship Information page for an overview, qualifications, and application details.

Hepatitis Virus Infections and their Relationship to Liver Cancer – Postdoctoral Fellowship

Dr. Thomas O’Brien of the Infections and Immunoepidemiology Branch (IIB) is seeking a postdoctoral fellow to conduct studies of hepatitis virus infections and the relationship of these infections to liver cancer. His research program emphasizes translating scientific findings for clinical and public health benefits. Specific areas of Dr. O’Brien’s research include:

  1. IFNL4 Genotype and Hepatitis C Virus Infection
    Dr. O’Brien provided the epidemiological leadership for studies that led to the discovery of a novel gene that determines HCV clearance.
  2. Hepatitis D Virus Infection and Liver Cancer
    HDV is the most pathogenic virus for the risk of liver cancer. Dr. O’Brien conducts studies of HDV in the United States and Africa.
  3. Surveillance Studies of Hepatitis Virus-associated Liver Cancer
    New therapies promise to reduce the incidence of liver cancer in the United States and around the world. Surveillance studies examine if the availability of these therapies is fulfilling public health goals.

Qualifications: Individuals must either hold, or expect to soon attain, a medical degree, a doctorate degree in epidemiology or a doctorate degree in a related field. Review of applications will be conducted periodically and continue until the position is filled. Applicants may be U.S. citizens or permanent residents; for a visiting fellowship, visa requirements apply Postdoctoral Fellowship positions are subject to a background investigation. DHHS, NIH and NCI are Equal Opportunity Employers and are dedicated to building a diverse community in their training and employment programs.

For more information about this position, please contact: Thomas O’Brien, M.D., M.P.H., senior investigator.

To Apply: See the Division Fellowship Information page for an overview, qualifications, and application details.

DHHS and NIH are Equal Opportunity Employers